Pharmacokinetic Analysis of Weekly Versus Biweekly IgPro20 Dosing in Patients With Primary Immunodeficiency

Flexible dosing of IgPro20 (Hizentra®, CSL Behring, King of Prussia, Pennsylvania) maintains normal serum immunoglobulin G (IgG) levels in patients with primary immunodeficiencies (PID). Until now, clinical trials testing the pharmacokinetic (PK) characteristics of serum IgG of weekly and biweekly s...

Descripción completa

Detalles Bibliográficos
Autores principales: Rojavin, Mikhail A., Chapdelaine, Hugo, Tortorici, Michael A., Praus, Michaela, Baheti, Gautam, Zhang, Ying, Hofmann, Jutta, Labrosse, Roxane, Dicaire, Renée, Haddad, Elie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7586812/
https://www.ncbi.nlm.nih.gov/pubmed/31814328
http://dx.doi.org/10.1002/cpdd.753

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7586812/
https://www.ncbi.nlm.nih.gov/pubmed/31814328
http://dx.doi.org/10.1002/cpdd.753

Ejemplares similares